Tags

Type your tag names separated by a space and hit enter

Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease.
J Vasc Surg. 2001 Feb; 33(2):320-7; discussion 327-8.JV

Abstract

PURPOSE

Venous reconstructions are rarely performed, and factors affecting long-term results of bypass grafts implanted in the venous system are not well defined. In this report we updated our experience.

METHODS

The clinical data of all patients who underwent venous reconstruction for iliofemoral or inferior vena caval (IVC) occlusion due to nonmalignant disease between January 1985 and June 1999 were retrospectively reviewed. Patients were classified, and outcomes were compared according to the guidelines of the Joint Vascular Societies.

RESULTS

Forty-two patients, 23 males and 19 females (mean age, 40 years; range, 16-81), underwent 44 venous reconstructions. Thirty-six patients had limb swelling or venous claudication, 38 had pain, and 14 had healed or active ulcers. The cause of obstruction was congenital in two and acquired in 40 (deep vein thrombosis, 25; trauma, 5; retroperitoneal fibrosis, 4; IVC occlusion devices, 4; others, 2). Eighteen patients underwent saphenous vein crossover grafts (Palma procedure), 17 had expanded polytetrafluoroethylene (ePTFE) grafts implanted (femorocaval, 8; iliocaval, 5; crossfemoral, 3; cavoatrial, 1), 6 patients had spiral vein grafts (5 iliac/femoral and 1 cavoatrial), and 1 underwent femoral vein patch angioplasty. Clinical follow-up averaged 3.5 years (median, 2.5), and graft follow-up with imaging studies averaged 2.6 years (median, 1.6). Seven patients were lost to follow-up. The secondary 3-year patency rate for all reconstructions was 62%. Palma procedures had a 4-year patency rate of 83%. The secondary patency rate of iliocaval and femorocaval ePTFE bypass grafts at 2 years was 54%. The secondary patency was lower in patients with an arteriovenous fistula (P =.023). All ePTFE grafts had a 45% patency rate at 2 years, not significantly different from saphenous vein grafts (83%, P =.16). Clinical scores improved with graft patency (median, 0.0 vs 1.5; P =.044).

CONCLUSIONS

Venous reconstructions for iliofemoral or IVC obstruction offer 3-year patency rates of 62%. The Palma procedure with autologous saphenous vein had the best long-term patency, whereas long-term success with ePTFE was moderate. The use of an arteriovenous fistula to improve graft patency remains controversial.

Authors+Show Affiliations

Division of Vascular Surgery, the Department of Diagnostic Radiology, and the Section of Biostatistics, Mayo Clinic, Rochester, Minn., USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11174784

Citation

Jost, C J., et al. "Surgical Reconstruction of Iliofemoral Veins and the Inferior Vena Cava for Nonmalignant Occlusive Disease." Journal of Vascular Surgery, vol. 33, no. 2, 2001, pp. 320-7; discussion 327-8.
Jost CJ, Gloviczki P, Cherry KJ, et al. Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease. J Vasc Surg. 2001;33(2):320-7; discussion 327-8.
Jost, C. J., Gloviczki, P., Cherry, K. J., McKusick, M. A., Harmsen, W. S., Jenkins, G. D., & Bower, T. C. (2001). Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease. Journal of Vascular Surgery, 33(2), 320-7; discussion 327-8.
Jost CJ, et al. Surgical Reconstruction of Iliofemoral Veins and the Inferior Vena Cava for Nonmalignant Occlusive Disease. J Vasc Surg. 2001;33(2):320-7; discussion 327-8. PubMed PMID: 11174784.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease. AU - Jost,C J, AU - Gloviczki,P, AU - Cherry,K J,Jr AU - McKusick,M A, AU - Harmsen,W S, AU - Jenkins,G D, AU - Bower,T C, PY - 2001/2/15/pubmed PY - 2001/3/27/medline PY - 2001/2/15/entrez SP - 320-7; discussion 327-8 JF - Journal of vascular surgery JO - J Vasc Surg VL - 33 IS - 2 N2 - PURPOSE: Venous reconstructions are rarely performed, and factors affecting long-term results of bypass grafts implanted in the venous system are not well defined. In this report we updated our experience. METHODS: The clinical data of all patients who underwent venous reconstruction for iliofemoral or inferior vena caval (IVC) occlusion due to nonmalignant disease between January 1985 and June 1999 were retrospectively reviewed. Patients were classified, and outcomes were compared according to the guidelines of the Joint Vascular Societies. RESULTS: Forty-two patients, 23 males and 19 females (mean age, 40 years; range, 16-81), underwent 44 venous reconstructions. Thirty-six patients had limb swelling or venous claudication, 38 had pain, and 14 had healed or active ulcers. The cause of obstruction was congenital in two and acquired in 40 (deep vein thrombosis, 25; trauma, 5; retroperitoneal fibrosis, 4; IVC occlusion devices, 4; others, 2). Eighteen patients underwent saphenous vein crossover grafts (Palma procedure), 17 had expanded polytetrafluoroethylene (ePTFE) grafts implanted (femorocaval, 8; iliocaval, 5; crossfemoral, 3; cavoatrial, 1), 6 patients had spiral vein grafts (5 iliac/femoral and 1 cavoatrial), and 1 underwent femoral vein patch angioplasty. Clinical follow-up averaged 3.5 years (median, 2.5), and graft follow-up with imaging studies averaged 2.6 years (median, 1.6). Seven patients were lost to follow-up. The secondary 3-year patency rate for all reconstructions was 62%. Palma procedures had a 4-year patency rate of 83%. The secondary patency rate of iliocaval and femorocaval ePTFE bypass grafts at 2 years was 54%. The secondary patency was lower in patients with an arteriovenous fistula (P =.023). All ePTFE grafts had a 45% patency rate at 2 years, not significantly different from saphenous vein grafts (83%, P =.16). Clinical scores improved with graft patency (median, 0.0 vs 1.5; P =.044). CONCLUSIONS: Venous reconstructions for iliofemoral or IVC obstruction offer 3-year patency rates of 62%. The Palma procedure with autologous saphenous vein had the best long-term patency, whereas long-term success with ePTFE was moderate. The use of an arteriovenous fistula to improve graft patency remains controversial. SN - 0741-5214 UR - https://www.unboundmedicine.com/medline/citation/11174784/Surgical_reconstruction_of_iliofemoral_veins_and_the_inferior_vena_cava_for_nonmalignant_occlusive_disease_ DB - PRIME DP - Unbound Medicine ER -